Results 201 to 210 of about 135,428 (332)

Advances in Erectile Dysfunction Management: What Does Work

Trends in Urology &Men's Health, Volume 17, Issue 3, June 2026.
ABSTRACT Erectile dysfunction (ED) is a prevalent and multifactorial disorder that substantially affects quality of life. Pathophysiology includes vascular, neurogenic, drug‐induced, and psychogenic causes, and frequently coexists with cardiometabolic disease.
Jolie Shen, Daye Park, Jasper Bash, Juan Andino   +3 more
wiley   +1 more source

Lipidomic profiling reveals medium-chain acylcarnitines alterations as metabolic signatures in IgA nephropathy. [PDF]

BMC Nephrol
Cheng J, Han Y, Zhang Y, He X, Zou S, She W, Peng Z, Huang L, Huang H.   +8 more
europepmc   +1 more source

Effects of Ractopamine HCL, L-Carnitine and dried distillers grains with solubles on growth, carcass traits, loin and jowl fat quality of finishing pigs, and energy and protein sources in nursery diets

, 2011
Ying, Wei
openalex   +1 more source

GLP‐1 agonists and the gut microbiome: A bidirectional relationship

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1309-1325, May 2026.
Abstract Glucagon‐like peptide‐1 (GLP‐1) receptor agonists have transformed the management of type 2 diabetes mellitus (T2DM) and obesity, yet their interactions with the gut microbiome remain an emerging frontier in pharmacological and metabolic research.
Srinivas Kamath, Nicole S. L. Chan, Paul Joyce   +2 more
wiley   +1 more source

Metabolite biomarkers present in urine predict alterations in skeletal muscle associated with sarcopenia. [PDF]

Front Aging
Andrade-Vieira R, Feridooni HA, Teixeira A, Deska-Gauthier D, Chang X, Karakach T, Moyer R, Frampton JP.   +7 more
europepmc   +1 more source

Fat balance and hepatic mitochondrial function in response to fat feeding in mature rats. [PDF]

, 1999
BARLETTA, ANTONIO, IOSSA, SUSANNA, Lionetti L., LIVERINI, GIOVANNA, MOLLICA, MARIA PINA   +4 more
core   +1 more source

Corrigendum to “Primary carnitine deficiency cardiomyopathy” [Int J Cardiol 2014;174:171–173] [PDF]

, 2014
Shushui Wang, Jiao Rao, Yufen Li, Zhiwei Zhang, Guohong Zeng   +4 more
openalex   +1 more source

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV: An Emerging Frontier for Clinical Pharmacology

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1136-1140, May 2026.
As antiretroviral therapy (ART) prolongs lifespans, people with HIV (PWH) face a new syndemic: Cardiovascular‐Kidney‐Metabolic (CKM) syndrome. Yet CKM in PWH is poorly characterized. Inflammation, complex pharmacokinetic (PK) alterations, ART‐associated metabolic effects, and gut dysbiosis amplify risk. Managing CKM increases medication burden, thereby
Aaron S. Devanathan, Thomas D. Nolin
wiley   +1 more source

Altered Carnitine Homeostasis Modulates Hyperosmolarity-Induced Mitochondrial Dysfunction and Lipotoxicity in Human Corneal Epithelial Cells. [PDF]

Invest Ophthalmol Vis Sci
Kontoh-Twumasi R, Aliste A, Scheid A, Lax K, Glass J, Sharma A, Sharma S.   +6 more
europepmc   +1 more source

Comparative Efficacy and Safety of Resmetirom and Efruxifermin for Metabolic Dysfunction‐Associated Steatohepatitis: A Network Meta‐Analysis of Randomized Controlled Trials

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This meta‐analysis compared Resmetirom and Efruxifermin in patients with MASH, focusing on improvements in key biochemical and non‐invasive markers. Efruxifermin is associated with favourable outcomes with a slightly greater effect on MRI‐PDFF and AST, along with more comparable safety outcomes.
Doha Jaber, Inas Jaber, Ayah Abu Lehia, Thekrayat Asad, Hazem Ayesh   +4 more
wiley   +1 more source